Background: Chagas disease, resulting from the protozoan Trypanosoma cruzi, is an
important cause of heart failure, stroke, arrhythmia, and sudden death. Traditionally …

The recommendations listed in this guideline are, whenever possible, evidence based. An
initial extensive evidence review, which included literature derived from research involving …

Chagas heart disease (CHD) affects approximately 30% of patients chronically infected with
the protozoa Trypanosoma cruzi. CHD is classified into four stages of increasing severity …

Background The clinical outcomes associated with Chagas disease remain poorly
understood. In addition to the burden of morbidity, the burden of mortality due to …

SciELO - Brazil - Diretriz da SBC sobre Diagnóstico e Tratamento de Pacientes com
Cardiomiopatia da Doença de Chagas – 2023 Diretriz da SBC sobre Diagnóstico e Tratamento …

Aims This study aimed to estimate the annual mortality risk and its determinants in chronic
Chagas cardiomyopathy. Methods and results We conducted a systematic search in …

Background Dysautonomia plays an ancillary role in the pathogenesis of Chronic Chagas
Cardiomyopathy (CCC), but is the key factor causing digestive organic involvement. We …

A DC (tripanossomíase americana) é entidade mórbida transmissível, potencialmente fatal,
causada pelo protozoário parasita T. cruzi e que integra o grupo de doenças tropicais …

Background Risk stratification of Chagas disease patients in the limited‐resource setting
would be helpful in crafting management strategies. We developed a score to predict 2‐year …

Background One of the significant problems in the field of healthcare is the low survival rate
of people who have experienced sudden cardiac arrest. Early prediction of cardiac arrest …